A Medicare coverage fight over DCIS biomarker testing raises a critical question: Who decides when the evidence is strong ...
Medicare contractors are considering whether to continue covering a breast cancer diagnostic test.
Researchers leading a trial of active surveillance for ductal carcinoma in situ (DCIS) have described early results as "reassuring" in a presentation at the 15th European Breast Cancer Conference ...
Ductal carcinoma in situ (DCIS) constitutes a non-invasive precursor to breast cancer in which malignant cells remain confined to the ductal system. Its detection has risen sharply with widespread ...
All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE) Tamoxifen 20 mg once-daily reduces the risk of breast cancer recurrence after ductal carcinoma in ...
ASCO's updated guideline on breast cancer follow-up recommends risk-based surveillance intensity and selective mammography ...
'Watch and Wait' Approach Safe For Women With Precancerous Breast Condition, Trial Finds By Dennis Thompson HealthDay ReporterTUESDAY, March 31, 2026 (HealthDay News) — A “watch and wait” approach ...
"Saturday Night Live" alum Cheri Oteri shared a cancer treatment milestone after she was diagnosed with ductal carcinoma in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results